AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PERINDOPRIL TERT-BUTYLAMINE + AMLODIPINE BESILATE

12 registrations across 2 African markets— 12 active

Markets with PERINDOPRIL TERT-BUTYLAMINE + AMLODIPINE BESILATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PERINAM DENK 8/5MG TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 4/5MG ​TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 8/10MG TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 4/10MGTABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 8/5MG TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 4/5MG ​TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 4/10MGTABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 8/10MG TABLETS🇬🇭GhanaactiveMay 2030
PERINAM DENK 4 MG/ 10 MG COMPRIMES BLANCS A BLANC CASSE BOITE DE 60🇨🇮Côte d'IvoireDENK PHARMA GMBH & CO. KGactiveJun 2029
PERINAM DENK 4MG/5MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireDENK PHARMA GMBH & CO. KGactiveOct 2028
PERINAM DENK 8MG/10MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireDENK PHARMA GMBH & CO. KGactiveOct 2028
PERINAM DENK 8MG/5MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireDENK PHARMA GMBH & CO. KGactiveOct 2028

PERINDOPRIL TERT-BUTYLAMINE + AMLODIPINE BESILATE in Africa — Regulatory Overview

PERINDOPRIL TERT-BUTYLAMINE + AMLODIPINE BESILATE is registered across 2 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.